To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM — Stella

Recruiting

Back to T2DM (Type 2 Diabetes Mellitus) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Korea

Korea University Anam Hospital, Seoul

Key details

Sponsor

Korea University Anam Hospital

Enrollment target

~3,958 participants

Started

March 2024

Primary completion

February 2027

Age range

19 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov